Laxmi Dental Limited

BSE: LAXMIDENTL544339ISIN INE0WO601020

Healthcare
Medical Equipment & Supplies
BSE Healthcare

Share price

₹188.30+6.25 (+3.43%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹344.60
52W low: ₹155.65
Off 52W high: -45.36%
1M return: -1.10%
3M return: -14.06%
6M return: -12.09%
1Y return: -40.71%
20D avg volume: 5,742
50 DMA: ₹191.57
200 DMA: ₹203.05

Key ratios Consolidated

Market cap: ₹1,036 Cr
Current price: ₹188.30
52W high / low: ₹344.60 / ₹155.65
Face value: ₹2.00
P/E: 31.98
P/B: 3.91
EPS (TTM): ₹5.89
Book value / share: ₹48.13
ROE: —
ROCE: 11.50%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-8.40 Cr
Interest cover: 22.12
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 74.4 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q4 FY24
Income statement
	79.52	74.70	73.95	66.04	72.27	65.60	60.67	61.66	—
	2.17	2.30	2.36	2.08	2.39	1.72	1.63	0.59	—
	81.69	76.99	76.31	68.12	74.65	67.32	62.30	62.25	—
	69.95	64.95	65.18	63.57	65.23	57.72	56.70	57.53	—
	15.38	9.11	11.80	4.00	6.94	2.35	4.11	6.88	—
	0.79	9.63	12.93	15.44	15.59	13.60	9.25	7.73	—
	31.15	28.42	26.76	25.94	25.77	23.63	24.41	21.76	—
	0.40	0.30	0.34	0.32	0.24	0.46	1.26	1.53	—
	5.30	4.32	4.38	4.17	3.75	3.58	4.30	3.95	—
	14.78	15.92	11.87	13.02	12.73	12.55	13.85	14.19	—
	11.73	12.04	11.14	4.55	9.42	9.60	5.60	4.71	—
	0.00	0.00	0.00	-5.78	0.00	0.00	0.41	0.00	—
	11.73	12.04	11.14	-1.23	9.42	9.60	6.01	4.71	—
	2.23	2.49	0.50	-2.16	1.86	2.29	2.48	1.07	—
	10.04	10.31	10.10	1.96	8.53	8.33	4.28	4.82	—
	1.82	1.87	1.83	0.37	1.59	1.53	0.79	0.88	—
Key metrics
	17.43	16.66	15.86	3.26	13.41	13.64	11.57	10.19	—
	21.90%	22.30%	21.40%	4.90%	18.60%	20.80%	19.10%	16.50%	—
	12.60%	13.80%	13.70%	3.00%	11.80%	12.70%	7.10%	7.80%	—
	4.30%	—	4.40%	—	4.00%	—	3.20%	—	—
	10.00%	13.90%	21.90%	7.10%	—	—	—	—	—
	17.70%	23.80%	136.00%	-59.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	294.21	277.86	239.11	—
	8.91	8.55	3.34	—
	303.11	286.40	242.44	—
	263.65	251.70	217.64	—
	40.29	25.10	37.23	—
	38.79	57.56	19.46	—
	112.27	102.10	85.77	—
	1.36	1.37	5.39	—
	18.17	15.88	15.02	—
	55.59	50.17	54.23	—
	39.46	34.70	24.80	—
	-5.78	-5.78	7.03	—
	33.68	28.93	31.83	—
	3.06	2.50	6.45	—
	32.41	28.92	31.83	—
	5.89	5.53	6.20	—
Key metrics
	53.21	46.18	52.24	—
	18.09%	16.60%	21.80%	—
	11.02%	10.40%	13.30%	—
	—	11.50%	16.30%	—
	13.07%	16.20%	—	—
	24.85%	-9.10%	—	—
	—	-21.28	28.71	—
	—	-0.17	1.38	—
	—	0.00	0.05	—
	—	-8.40	-79.45	—
	—	74.4	35.6	—
Balance sheet
	—	293.97	284.67	—
	—	191.35	187.06	—
	—	8.40	90.82	—
	—	45.54	36.68	—
	—	21.75	18.65	—
	—	17.15	16.09	—
	—	59.24	41.13	—
	—	10.68	32.06	—
	—	30.79	56.70	—
	—	0.00	11.37	—
	—	0.00	0.76	—
	—	0.00	10.61	—
	—	244.11	208.70	—
Cash flow
	—	-5.00	43.83	—
	—	-79.58	-29.24	—
	—	-17.75	110.64	—
	—	16.28	15.12	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q4 FY24
Income statement
	58.19	55.20	55.74	48.45	54.26	50.11	42.69	43.34	—
	1.50	1.71	1.99	2.01	2.37	1.66	2.18	0.87	—
	59.68	56.91	57.73	50.46	56.63	51.77	44.86	44.21	—
	53.68	49.86	51.15	47.18	49.35	42.78	38.87	41.44	—
	13.51	15.39	17.63	10.03	12.56	8.06	5.50	11.61	—
	0.78	1.44	3.31	5.31	7.20	5.09	5.75	1.34	—
	23.38	21.96	21.85	20.09	19.48	17.45	17.83	15.45	—
	0.30	0.26	0.27	0.23	0.14	0.14	0.70	1.01	—
	3.94	3.26	3.33	3.06	2.64	2.48	2.83	2.67	—
	9.83	10.26	7.82	8.23	7.92	7.27	7.52	7.77	—
	6.00	7.05	6.58	3.27	7.28	9.00	5.99	2.77	—
	0.00	0.00	0.00	-5.16	0.00	0.00	0.41	—	—
	6.00	7.05	6.58	-1.88	7.28	9.00	6.40	2.77	—
	1.87	1.77	-0.38	1.05	1.72	2.16	2.97	0.73	—
	4.67	6.17	6.80	-1.89	6.57	7.86	4.17	3.21	—
	0.85	1.12	1.24	-0.34	1.20	1.43	0.77	0.59	—
Key metrics
	10.24	10.57	10.18	1.41	10.06	11.62	9.93	6.45	—
	17.60%	19.10%	18.30%	2.90%	18.50%	23.20%	23.30%	14.90%	—
	8.00%	11.20%	12.20%	-3.90%	12.10%	15.70%	9.80%	7.40%	—
	2.30%	—	2.60%	—	3.00%	—	3.10%	—	—
	7.20%	10.20%	30.60%	11.80%	—	—	—	—	—
	-28.90%	-21.50%	63.10%	-158.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	217.58	208.56	171.24	—
	7.21	8.03	4.62	—
	224.78	216.58	175.86	—
	201.87	190.46	158.54	—
	56.56	48.30	42.55	—
	10.84	20.91	11.29	—
	87.28	78.88	61.06	—
	1.06	0.78	3.65	—
	13.59	11.51	9.82	—
	36.14	31.24	29.43	—
	22.90	26.13	17.33	—
	-5.16	-5.16	7.03	—
	17.75	20.97	24.35	—
	4.31	4.54	5.75	—
	15.75	19.34	25.77	—
	2.87	3.52	4.92	—
Key metrics
	32.40	33.26	37.82	—
	14.89%	15.90%	22.10%	—
	7.24%	9.30%	15.00%	—
	—	8.20%	12.20%	—
	14.28%	21.80%	—	—
	-27.79%	-25.00%	—	—
	—	-50.52	34.72	—
	—	-1.82	1.83	—
	—	0.00	0.00	—
	—	-3.88	-88.48	—
	—	75.8	40.7	—
Balance sheet
	—	288.76	272.99	—
	—	146.89	181.20	—
	—	3.88	88.48	—
	—	30.99	31.71	—
	—	20.69	16.67	—
	—	14.91	10.67	—
	—	50.81	33.29	—
	—	8.36	29.29	—
	—	24.52	43.25	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	247.05	222.74	—
Cash flow
	—	-35.26	47.06	—
	—	-45.92	-48.67	—
	—	-3.43	103.60	—
	—	15.26	12.34	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +14.28%
Profit YoY (TTM): -27.79%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +13.07%
Profit YoY (TTM): +24.85%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 41.75%

Quarter	September 2026	June 2026	March 2026
Promoter %	41.75%	41.80%	41.76%

Holder	Type	Holding	Previous	Change
ORBIMED ASIA II MAURITIUS LIMITED	Public	22.38%	22.41%	-0.03%
Rajesh Vrajlal Khakhar	Promoter	16.93%	16.95%	-0.02%
Sameer Kamlesh Merchant	Promoter	15.81%	15.83%	-0.02%
Jigna Rajesh Khakhar	Promoter Group	7.83%	7.84%	-0.01%
ICICI PRUDENTIAL HEALTHCARE FUND	Public	4.41%	—	—
GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIO	Public	3.49%	3.50%	-0.01%
AMRISH DESAI	Public	2.01%	2.02%	-0.01%
PARAG JAMNADAS BHIMJIYANI	Public	2.01%	2.02%	-0.01%
UTI-HEALTHCARE FUND	Public	1.46%	1.09%	+0.37%
HDFC MUTUAL FUND - HDFC CONSUMPTION FUND	Public	1.37%	—	—
ASHOKA INDIA EQUITY INVESTMENT TRUST PLC	Public	1.01%	1.13%	-0.12%
Kunal K Merchant	Promoter Group	0.92%	0.92%	0.00%
Dharmesh Bhupendra Dattani	Promoter	0.24%	0.24%	0.00%
Hasmukh Vrajlal Khakhar	Promoter Group	0.02%	0.02%	0.00%
Bhavna Bhupendra Dattani	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Poly Medicure Ltd	16,093	1,587.65	51.43	13.20%	+18.31% TTM	-12.49% TTM	-18.70%
MOLBIO DIAGNOSTICS LIMITED	15,901	1,379.80	—	—	—	—	—
Sahajanand Medical Technologies Limited	4,939	485.85	—	—	—	—	—
FISCHER MEDICAL VENTURES LIMITED	1,655	25.29	59.29	12.70%	+195.94% TTM	+371.52% TTM	-73.00%
Tarsons Products Limited	1,651	310.35	148.83	4.80%	+10.63% TTM	-59.68% TTM	+7.85%
Laxmi Dental Limited	1,036	188.30	31.98	11.50%	+13.07% TTM	+24.85% TTM	-40.71%
Hemant Surgical Industries Limited	884	608.10	—	19.50%	—	—	+109.69%
Fabtech Technologies Limited	591	133.05	16.61	11.60%	—	—	-44.16%
Prevest Denpro Limited	480	400.00	—	21.90%	—	—	-23.80%
Nureca Limited	288	301.65	60.46	3.40%	+33.66% TTM	+15.82% TTM	+17.10%
EARKART LIMITED S	161	117.00	32.59	12.10%	—	—	-48.46%
CHOKSI ASIA LIMITED S	120	210.00	23.08	18.40%	+21.40% TTM	+132.74% TTM	+97.28%
Shree Pacetronix Ltd	63	169.15	19.60	25.00%	+22.63% TTM	+208.57% TTM	-38.65%
Amkay Products Limited S	46	53.50	20.04	13.40%	—	—	+13.88%
KMS Medisurgi Limited S	44	132.80	177.07	4.80%	—	—	—
Royal Sense Limited	36	67.70	—	26.10%	—	—	-70.69%
GKB Ophthalmics Ltd.	31	62.00	5.67	9.60%	+29.95% TTM	+170.50% TTM	-9.48%
Centenial Surgical Suture Ltd. S	26	71.96	-17.99	2.60%	+6.70% TTM	+26.29% TTM	-33.37%
Transpact Enterprises Limited S	4	100.70	—	14.50%	—	—	-57.35%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Kids-e-Dental LLP ("KED"), a jointly controlled entity of the Company in which the Company holds 60% interest, has today, i.e. November 4, 2026, received the EU Quality Management System ....4 Nov 2026 · Company Update / General
Earnings Conference Call Recordings4 Nov 2026 · Company Update / Analyst / Investor Meet
Announcement under Regulation 30 (LODR)-Press Release / Media Release3 Nov 2026 · Company Update / Press Release / Media Release
Earnings call Presentation3 Nov 2026 · Company Update / Investor Presentation
Financial Results For The Quarter And Half Year Ended September 30, 20263 Nov 2026 · Result / Financial Results
Outcome of Board Meeting of Laxmi Dental Limited held on Tuesday, November 03, 2026 for approval of un-audited financial results (consolidated and standalone) for the quarter and half year ....3 Nov 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 04th November, 2026.28 Oct 2026 · Company Update / Analyst / Investor Meet
Laxmi Dental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Laxmi Dental Limited has informed ....28 Oct 2026 · Board Meeting / Board Meeting
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.21 Oct 2026 · Company Update / Acquisition
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.21 Oct 2026 · Company Update / General
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 15th October, 2026.10 Oct 2026 · Company Update / Analyst / Investor Meet
Intimation of Monitoring Agency Report for the quarter ended September 30, 2026.8 Oct 2026 · Company Update / Monitoring Agency Report
Board comments on fine levied by BSE and NSE for delay in compliance under Regulation 29 of Listing Regulations.8 Oct 2026 · Company Update / General
Board of Directors of the Company, at its meeting held today, i.e., Thursday, October 08, 2026, has, inter alia, considered and approved the proposal for the Company to become a member ....8 Oct 2026 · Company Update / Acquisition
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30, 2026.8 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Voting Results and Scrutiniser''s Report for 22nd AGM of the Company for FY 2026.29 Sep 2026 · AGM/EGM / AGM
Proceeding of the 22nd Annual General Meeting of the Company held on Friday, September 25, 2026.25 Sep 2026 · AGM/EGM / AGM
Intimation of Closure of Trading Window for quarter and half year ended September 30, 2026.25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 29th September, 2026.23 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 to be held on 28th September, 2026.23 Sep 2026 · Company Update / Analyst / Investor Meet
National Stock Exchange of India Limited (''NSE'') and BSE Limited (''BSE'') have issued their respective approvals for listing of further issue of 7,911 Equity Shares of face value of ....18 Sep 2026 · Company Update / General
Intimation of Schedule of Analyst/ Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.4 Sep 2026 · Company Update / Analyst / Investor Meet
Completion of dispatch of the Annual Report for the Financial Year ("FY") 2025-2026 including Notice of the 22nd Annual General Meeting (AGM)4 Sep 2026 · Company Update / Newspaper Publication
Notice convening the 22nd Annual General Meeting ('AGM') and submission of Annual Report for Financial Year 2025-263 Sep 2026 · Others / Reg. 34 (1) Annual Report
Intimation of 22nd Annual General Meeting ('AGM') of the Company scheduled to be held on Friday, September 25, 2026.3 Sep 2026 · AGM/EGM / AGM
Newspaper advertisement for proposed Variation in the Objects/Terms of Utilization of the Initial Public Offering ("IPO") Proceeds and Modification of the Time Limit for Utilization of IPO Proceeds.3 Sep 2026 · Company Update / Newspaper Publication
Newspaper Publication for 22nd Annual General Meeting of the Company.2 Sep 2026 · Company Update / Newspaper Publication
National Stock Exchange of India Limited ('NSE') and BSE Limited ('BSE') have issued their respective approvals for listing of further issue of 59,360 Equity Shares of face value of Rs. ....31 Aug 2026 · Company Update / General
Intimation of Closure of Trading window for all Designated Persons, Connected Persons and their immediate relatives from Thursday, August 27, 2026 till 48 hours after the declaration of ....27 Aug 2026 · Insider Trading / SAST / Closure of Trading Window
Allotment of 7,911 Equity Shares of face value of INR. 2 each under Laxmi Dental Stock Options Scheme 2024.27 Aug 2026 · Company Update / Allotment of ESOP / ESPS
Outcome of Board Meeting of Laxmi Dental Limited held on Thursday, August 27, 202627 Aug 2026 · Others / Outcome without intimation
Earnings Call Transcript Q1FY2719 Aug 2026 · Company Update / Earnings Call Transcript
Extract of newspaper advertisements published on August 13, 2026, in the Financial Express (English Newspaper) and Mumbai Lakshdeep (Marathi Newspaper), with respect to Unaudited Standalone ....13 Aug 2026 · Company Update / Newspaper Publication
Q1FY27 Earnings Conference Call Recordings12 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation of Press Release11 Aug 2026 · Company Update / Press Release / Media Release
Earnings call Presentation.11 Aug 2026 · Company Update / Investor Presentation
Intimation of Monitoring Agency Report for the quarter ended June 30, 2026.11 Aug 2026 · Company Update / Monitoring Agency Report
Board of Directors at its meeting held today, August 11, 2026 has noted and approved surrender of 1,636 ESOP from Mr. Ansari Mohammed Saad.11 Aug 2026 · Company Update / General
Allotment of 59,360 Equity Shares of face value of INR. 2 each under Laxmi Dental Stock Options Scheme 2024.11 Aug 2026 · Company Update / Allotment of ESOP / ESPS
Declaration of Unaudited Financial Results for the quarter ended June 30, 2026.11 Aug 2026 · Result / Financial Results

Board meetings

3 Nov 2026 Board Meeting - Financial Results
11 Aug 2026 Board Meeting - Financial Results